Condition: Brain Stroke · Stenting Treatment · Acute Ischemic Stroke · Sponsor: ProMedica Health System
The study objective is to establish the safety and efficacy of endovascular adjunct stenting for patients undergoing mechanical thrombectomy (MT) that are found to have residual stenosis (70-99%) following attempted clot retrieval with either aspiration catheters or stent retrievers, per device instructions for use and device labeling.
This description comes directly from the study's public registry record.
Sami Al Kasab, MD · 4192913498 · alkasab@musc.edu
Mouhammad Jumaa, MD · Mouhammad.JumaaMD@ProMedica.org
Always discuss trial participation with your own doctor first.
| ProMedica Toledo Hospital | Toledo, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07356284